Trial Profile
Multiple-dose Pharmacokinetics of Doripenem During Continuous Venovenous Hemodiafiltration and Molecular Adsorbent Recirculating System in ICU Patients and During Hemodialysis in Longterm Hemodialysis Patients.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Doripenem (Primary)
- Indications Bacterial infections
- Focus Pharmacokinetics
- Acronyms DORIPENEM IN CVVH, MARS AND HD
- 27 Mar 2014 Trial status changed to completed as reported by ClinicalTrials.gov.
- 27 Jan 2014 New trial record